975 F. Supp. 2d 81
D.D.C.2013Background
- Public Citizen filed a FOIA request for annual Corporate Integrity Agreement (CIA) reports that Pfizer and Purdue submitted to HHS-OIG following settlements for alleged off-label promotion and related misconduct; HHS located thousands of pages and largely withheld them under FOIA Exemptions 4 and 6.
- CIAs required companies to submit annual reports including Reportable Event summaries, disclosure-log summaries, IRO (Independent Review Organization) reports, communications with FDA, screening/removal of Ineligible Persons, Pfizer’s off-label findings and detailing-session materials, and a 2009 Purdue supplement.
- Pfizer and Purdue pre-marked submissions “Confidential and FOIA Exempt”; HHS provided predisclosure notices and claimed many pages were exempt; plaintiffs appealed administratively and then sued.
- The parties produced Vaughn indices and declarations; the Court found many declarations and index entries conclusory and insufficiently tied to specific documents, complicating review.
- The Court held portions of the records are commercial and confidential under Exemption 4 and properly withheld (e.g., IRO reports, Pfizer off-label findings, changes to processes for Ineligible Persons, parts of Purdue’s promotional monitoring program), but ordered release of certain non-commercial items (names/titles/responsibilities of Ineligible Persons and the identity/status of investigating agencies) and found HHS’s search inadequate regarding Pfizer’s Section V.B.6 submissions.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Adequacy of search for Pfizer Section V.B.6 responses | Pfizer’s required Section V.B.6 responses are missing from Vaughn index/releases; HHS must search further | HHS contends it conducted a reasonable search and identified related letters in Vaughn entries 174–176 | Search inadequate; HHS must supplement declarations or search further because records for at least two years appear unaccounted for |
| Whether withheld materials are "commercial" under Exemption 4 | Information about illegal or corrective conduct is non- commercial and falls outside Exemption 4 | Much of the withheld material (marketing, sales processes, IRO reviews, off-label findings, promotional monitoring) is commercial or implicates commercial interests | Court rejects categorical rule excluding wrongdoing-related materials; finds many categories are commercial but several require more factual support before ruling |
| Whether commercial materials are "confidential" (National Parks test) | Public disclosure is in public interest; plaintiff challenges showing of likely competitive harm or impairment of government information-gathering | HHS/companies assert disclosure would impair government’s ability to obtain information and cause substantial competitive harm | Government unlikely-to-obtain argument rejected; for several categories (IRO reports, Pfizer off-label findings, process changes re: Ineligible Persons, Purdue promotional monitoring) court finds likely competitive harm and upholds withholding; for other categories (disclosure logs, Reportable Events summaries, FDA communications, detailing session records, descriptions of allegations) declarations are insufficient and withholding denied without prejudice |
| Segregability and Exemption 6 privacy claims | Plaintiff narrowed privacy challenge; seeks release of non-privacy commercial data | HHS withheld some personal identifiers under Exemption 6 but plaintiff is not contesting names/contacts | Court requires agencies to produce any reasonably segregable nonexempt portions; ordered release of specified non-commercial details (names/titles/responsibilities of Ineligible Persons and identity/status of investigatory agencies); Exemption 6 not otherwise litigated here |
Key Cases Cited
- Pub. Citizen Health Research Group v. FDA, 704 F.2d 1280 (D.C. Cir. 1983) (Exemption 4 commercial/confidential analysis and scope of "commercial")
- Nat’l Parks & Conserv. Ass’n v. Morton, 498 F.2d 765 (D.C. Cir. 1974) (two-prong test for confidentiality: impairment of government information-gathering or substantial competitive harm)
- Campbell v. U.S. Dep’t of Justice, 164 F.3d 20 (D.C. Cir. 1998) (agency must follow leads revealed during search and expand search when appropriate)
- Summers v. Dep’t of Justice, 140 F.3d 1077 (D.C. Cir. 1998) (court must verify validity of each claimed FOIA exemption via review of Vaughn index and affidavits)
- United Techs. Corp. v. U.S. Dep’t of Defense, 601 F.3d 557 (D.C. Cir. 2010) (Exemption 4 does not protect against reputational or marketplace embarrassment; focus on affirmative competitive use)